Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

133
Delayed Quote. Delayed London Stock Exchange - 08/29 11:35:00 am
1474.5 GBp   +0.79%
13h ago GLAXOSMITHKLINE : Assigned Patent
1d ago GLAXOSMITHKLINE : Ebola vaccine trials fast-tracked by international consor..
1d ago GLAXOSMITHKLINE : GSK receives FDA approval for Arnuity™ Ellipta® flu..
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012 | 04:46am US/Eastern
Recommend:
0

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
13h ago GLAXOSMITHKLINE : Assigned Patent
1d ago GLAXOSMITHKLINE : Ebola vaccine trials fast-tracked by international consortium
1d ago GLAXOSMITHKLINE : GSK receives FDA approval for Arnuity™ Ellipta® fluticas..
1d ago GLAXOSMITHKLINE : GSK Gets FDA Approval for Arnuity Ellipta (fluticasone furoate..
2d ago GLAXOSMITHKLINE : Glaxo Says FDA Approves Promacta SNDA In Aplastic Anaemia Pati..
3d ago GLAXOSMITHKLINE : Triumeq US Approval
4d ago GLAXOSMITHKLINE : *socgen raises glaxosmithkline price target to 1920 pence - 'b..
08/22 GLAXOSMITHKLINE : ViiV Healthcare receives FDA approval for Triumeq® (abacavir, ..
08/21 Healthcare stocks lift FTSE 100
08/21 Pfizer back for AstraZeneca? Year-end move seen most likely
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF